Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
            Where is AB4AD (Antibodies for Alzheimer's Disease) available for purchase?
          
 You can exchange AB4AD tokens on both decentralized and centralized crypto platforms. The favored choice for purchasing and trading AB4AD (Antibodies for Alzheimer's Disease) is Uniswap V3 (Base), notably the AB4AD/AB4AD pair, which saw a trading volume of $ 109.43 in the past day.   
            What is the highest value AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) has ever reached?
          
 AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) reached its peak price at 0.3761 $ on 15 September 2025, approximately 2 months ago ago. Presently, the current price is -71.22% lower than this all-time high.
 
            What is the historical minimum price for AB4AD (Antibodies for Alzheimer's Disease) (AB4AD)?
          
 The minimum price reached for AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) was 0.06263 $, documented on 17 October 2025, more than 13 days ago. In comparison, the current price is 72.79%, it above this historical low.
 
            What is the fully diluted valuation of AB4AD (Antibodies for Alzheimer's Disease) (AB4AD)?
          
 The fully diluted valuation (FDV) of AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) stands at $ 80,458. This figure reflects the maximum potential market capitalization, considering that the current circulating supply is at its maximum of 1,000,000 AB4AD tokens. The realization of this FDV might take several years depending on the emission schedule of AB4AD tokens.